RemedyAtlas
Back

Niacin

Supporting the management of high cholesterol and improving HDL-C levels.

Evidence · Grade A
Human trial evidenceTraditional useInteraction risk

Niacin is a vitamin-based intervention studied for its potential to improve lipid profiles, reduce oxidative stress, and support vascular health in patients with high cholesterol and atherosclerosis.

Last reviewed June 13, 2026 · AI-assisted, human-reviewed
Niacin, also known as vitamin B3, is a water-soluble micronutrient that has been utilized in therapeutic settings for its effects on lipid profiles. Clinical research has investigated its role in managing hypercholesterolemia and cardiovascular health, specifically focusing on its ability to alter lipoprotein concentrations. Beyond lipid management, niacin is studied for its physiological effects on vascular integrity and oxidative stress. Some formulations, such as extended-release niacin (Niaspan), have been observed in clinical trials to improve high-density lipoprotein cholesterol (HDL-C) and triglyceride levels. Additionally, niacin's vascular effects are explored through biomarkers like Fluorodeoxyglucose-PET/CT and measures of oxidative stress, though its overall impact on long-term cardiovascular outcomes remains a subject of ongoing scientific debate.

Quick answer

What it is: Niacin, also known as vitamin B3, is a water-soluble micronutrient that has been utilized in therapeutic settings for its effects on lipid profiles.

May support:High Cholesterol, Atherosclerosis

Evidence:Evidence · Grade A

Evidence Summary

Evidence · Grade A

Evidence from clinical trials involving various populations suggests niacin effectively alters lipid parameters. For instance, observations in Latin American cohorts indicated improvements in total cholesterol and HDL-C. Smaller trials have demonstrated its ability to reduce oxidative stress in hypercholesterolemic patients and potentially influence vascular health biomarkers over 12-week periods.

Last reviewed · Jun 2026

Have you tried Niacin?

Vote in 5 seconds. Add details if you want.

Your experience for High Cholesterol:

Commonly Combined With

Other remedies frequently used alongside this one — from curated relationships, community reports, and shared protocols.

Community signal breakdown

Where this remedy is being discussed across the web and community.

See Community Mentions

People Like Me insights

As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.

Community Discussions

What people say about Niacin

Search on Reddit →

Latest News

Latest news on Niacin

More on Google News →

Health Videos

Health videos on Niacin

More on YouTube

Why It Works

Niacin influences lipid metabolism by inhibiting the breakdown of fats in adipose tissue and reducing the liver's production of VLDL, thereby lowering LDL and increasing HDL levels.

How it works in more detail

Clinical observations suggest niacin may exert its effects by modulating oxidative stress markers, such as advanced oxidation protein products (AOPP). Studies have also utilized Fluorodeoxyglucose-PET/CT to investigate its impact on vascular inflammation and the mobilization of circulating endothelial progenitor cells. In some pharmacological combinations, niacin is paired with agents like laropiprant to mitigate the prostaglandin-mediated flushing response without interfering with the antiplatelet effects of aspirin or clopidogrel.

How to use

Always consult a qualified clinician.

Editorial guidance

Suggested dosage
For cholesterol management, doses typically range from 500 mg to 2000 mg per day, often starting low and titrating up to reduce side effects. This should be done under medical supervision.
Research dosage range
Dosages utilized in clinical settings vary by formulation; for example, extended-release versions are typically evaluated based on individual patient response to reach target lipid levels.
Typical onset
Changes in lipid markers or oxidative stress biomarkers have been observed in studies ranging from single-dose pharmacokinetics to 12-week clinical observation periods.
Typical forms
capsule, tablet, extended-release tablet
Quality markers
When purchasing niacin, look for products from reputable manufacturers that provide third-party testing for purity and potency. Check for the specific form of niacin (e.g., nicotinic acid, niacinamide, inositol hexanicotinate) as their effects and side effect profiles can differ. Extended-release fo
Medication interactions
  • Statins (increased risk of myopathy/rhabdomyolysis)
  • Anticoagulants (may increase bleeding risk)
  • Antihypertensive medications (may potentiate blood pressure lowering)
  • Oral hypoglycemic agents/insulin (may worsen glycemic control)
  • Alcohol (may exacerbate flushing and liver toxicity)
  • Bile acid sequestrants (may reduce niacin absorption)
Avoid if
  • Active liver disease
  • Severe hypotension
  • Active peptic ulcer disease
  • Arterial hemorrhage
  • Known hypersensitivity to niacin

Community tips

No community tips yet — be the first to share what worked for you.

Suggested dosage

For cholesterol management, doses typically range from 500 mg to 2000 mg per day, often starting low and titrating up to reduce side effects. This should be done under medical supervision.

General guidance — discuss specifics with a clinician.

Active medicinal compounds

Nicotinic acid (niacin) is the primary active compound responsible for the lipid-modifying effects. Niacinamide (nicotinamide) is another form of vitamin B3 but generally does not have the same lipid-lowering effects or flushing side effect.

Traditional use

Niacin, as a synthetic or isolated compound, does not have a history of traditional use in herbal medicine systems. Its therapeutic application for lipid disorders is a modern medical development. However, foods rich in niacin have always been part of traditional diets, contributing to overall health and preventing deficiency diseases like pellagra.

Safety

Safety warnings

Common side effects include cutaneous flushing, which is attributed to prostaglandin release. Niacin administration should be monitored for potential impacts on liver enzymes and glucose metabolism. It may also interact with antiplatelet medications, although research on specific combinations like laropiprant/niacin has shown no significant interference with clopidogrel and aspirin activity.

Avoid if

  • Active liver disease
  • Severe hypotension
  • Active peptic ulcer disease
  • Arterial hemorrhage
  • Known hypersensitivity to niacin

Medication interactions

  • Statins (increased risk of myopathy/rhabdomyolysis)
  • Anticoagulants (may increase bleeding risk)
  • Antihypertensive medications (may potentiate blood pressure lowering)
  • Oral hypoglycemic agents/insulin (may worsen glycemic control)
  • Alcohol (may exacerbate flushing and liver toxicity)
  • Bile acid sequestrants (may reduce niacin absorption)

Reported side effects

  • Flushing (redness, warmth, itching, tingling)
  • Gastrointestinal upset (nausea, vomiting, diarrhea)
  • Hepatotoxicity (liver damage)
  • Hyperglycemia (elevated blood sugar)
  • Hyperuricemia (elevated uric acid, potentially leading to gout)
  • Hypotension (low blood pressure)
  • Pruritus (itching)
  • Acanthosis nigricans (skin discoloration)

General guidance — discuss specifics with a clinician.

Evidence ecosystem

Scientific literature, clinical guidance, government sources, ongoing research, traditional use, and lived experience — grouped by source type and quality.

Overall grade (A)

Evidence from clinical trials involving various populations suggests niacin effectively alters lipid parameters. For instance, observations in Latin American cohorts indicated improvements in total cholesterol and HDL-C. Smaller trials have demonstrated its ability to reduce oxidative stress in hypercholesterolemic patients and potentially influence vascular health biomarkers over 12-week periods.

Clinical Trial Registries(5)

Registered ongoing or completed trials (ClinicalTrials.gov).

Moderate Quality

Limitations: Many studies on niacin utilize small sample sizes, such as those evaluating vascular health (n=9) or oxidative stress (n=30), which limits the generalizability of the findings. Furthermore, the clinical significance of niacin's effect on non-traditional biomarkers requires further validation through large-scale cardiovascular outcome trials.

This page is educational. Statements use phrases like "may support" and "has been studied for"because no remedy here is approved to cure, treat, or reverse any condition. Discussion happens on the ailment pages — community statistics here are derived from those reports. Always consult a qualified clinician.

Tried Niacin?

Help others see what actually works.